Join us as we delve into the incredible growth of Viking Therapeutics (NASDAQ: VKTX), a small-cap biotech company with promising drug candidates targeting the NASH and obesity markets. Learn about the potential of VK2809 and VK2735, as well as acquisition possibilities with major pharmaceutical companies. Will Viking's valuation reach new heights by the end of 2023? Watch to find out!
⚠️ Disclaimer: This video is for informational purposes only and is not financial advice. Always do your own research and consult a financial advisor before making investment decisions.
🔗 Visit StockToMe for more insights: [ Ссылка ]
🔔 Don't forget to subscribe for more exciting news from the world of biotechnology!
#VikingTherapeutics #NASH #Obesity #Biotech #StockToMe
Ещё видео!